The global oxygen concentrator market size is expected to reach USD 8.31 billion by 2033, registering a CAGR of 6.4% from 2025 to 2033, according to a new report by Grand View Research, Inc. The market growth is driven by several factors, including increasing incidence of respiratory diseases, introduction of advanced product offerings, expanding business operations, and a growing preference for home-based oxygen therapy. For instance, in October 2022, O2 Concepts launched Oxlife Liberty, a cutting-edge technology set to transform the oxygen therapy landscape. This demonstrates the industry's commitment to innovation. In addition, the market is expected to benefit from rising demand for portable oxygen concentrators due to a growing preference for home-based oxygen therapy. This trend is projected to fuel market growth from 2024 to 2030.
Rising government support, such as funding and initiatives for the development of healthcare infrastructure is anticipated to drive the demand for technologically advanced and cost-efficient devices over the forecast period. In addition, integration of Internet of Things (IoT) technology into oxygen concentrators has transformed the medical device industry, offering several advantages over traditional methods. By allowing for remote monitoring and management, IoT-enabled oxygen concentrators enable healthcare providers to monitor patients' oxygen levels in real-time and adjust the flow rate, leading to improved patient outcomes. This is expected to impel the market growth from 2024 to 2030.
Furthermore, prominent players in the industry, including Inogen, Inc., Respironics (a subsidiary of Koninklijke Philips N.V.), and Caire Medical (a subsidiary of NGK Spark Plug), are employing various strategies such as acquisitions, collaborations, expansions, and new product launches to extend the availability and geographical reach of their product offerings. For instance, in February 2023, React Health, a specialist in medical device development, manufacturing, and distribution, successfully acquired Invacare's Respiratory line. This strategic acquisition enhances React Health's market position, expands its product portfolio, and enables it to serve a wider range of customers.
Request a free sample copy or view report summary: Oxygen Concentrators Market Report
Based on product, fixed medical oxygen concentrators segment held the largest revenue share of over 54.1% in 2024, owing to its increasing demand among patients suffering from breathing problems
Based on technology, continuous flow segment held the largest revenue share of over 54.9% in 2024. This is attributed to the growing prevalence of long-term respiratory disorders such as asthma, COPD, bronchiectasis, and chronic sinusitis
The home care segment held the largest revenue share in 2024. Technological advancements and the adoption of home therapy in developed countries contribute significantly to the market's revenue share.
North America dominated the global market with a market share of over 41.0% in 2024, owing to the presence of advanced healthcare infrastructure, high investment in R&D, availability of the latest technologies, and product launches
Grand View Research has segmented the global oxygen concentrator market based on product, application, technology, region:
Oxygen ConcentratorProducts Outlook (Unit Volume, 000'; Revenue, USD Million, 2021 - 2033)
Portable Oxygen Concentrators
New Purchase
Rentals
Fixed Oxygen Concentrators
New Purchase
Rentals
Oxygen ConcentratorApplication Outlook (Unit Volume, 000'; Revenue, USD Million, 2021 - 2033)
Home Care
Non- Home Care
Oxygen ConcentratorTechnology Outlook (Unit Volume, 000'; Revenue, USD Million, 2021 - 2033)
Continuous Flow
Pulse Flow
Oxygen ConcentratorRegional Outlook (Unit Volume, 000'; Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Sweden
Denmark
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List Of Key Players Oxygen Concentrator Market
Respironics (a subsidiary of Koninklijke Philips N.V.) {Effective from January 25, 2024, Philips Respironics halted the sale of their POCs, with end of service scheduled for January 25, 2029.}
GF Health Products, Inc.
MedaCure Inc.
Nidek Medical Products, Inc
O2 Concepts
React Health
CAIRE Inc. (Acquired by Niterra Co., Ltd., formerly known as NGK SPARK PLUG CO., LTD.)
DeVilbiss Healthcare (a subsidiary of Drive Medical)
GCE Group
Compass Health Brands
Inogen, Inc.
Belluscura
Hoyo Scitech Co., Ltd.
BPL Medical Technologies
XNUO INTERNATIONAL GROUP (USA) HOLDING
Teijin Limited
BESCO MEDICAL LIMITED
Oxymed India
KALSTEIN FRANCE
Foshan Keyhub Electronic Industries Co., Ltd
"The quality of research they have done for us has been excellent..."